Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026)
Lifeward's (LFWD) quarterly Liabilities and Shareholders Equity came in at $33.4 million in Q1 2026, up 16.0% year-on-year from $28.8 million in Q1 2025, and up 45.93% quarter-over-quarter from $22.9 million in Q4 2025.
Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Lifeward has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $33.4 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $33.4 million, up 16.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.3 million (down 31.9% YoY), and the FY2025 annual result was $22.9 million, down 24.89% from the prior year.
- Liabilities and Shareholders Equity came in at $33.4 million for Q1 2026 at Lifeward, up from $22.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.0 million in Q1 2022 to a low of $22.9 million in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $55.2 million (2024), against an average of $53.9 million.
- Across the five-year window, Liabilities and Shareholders Equity grew 20.7% in 2022 and plunged 51.75% in 2024, its largest moves.
- Lifeward's Liabilities and Shareholders Equity stood at $74.2 million in 2022, then declined by 14.88% to $63.2 million in 2023, then plunged by 51.75% to $30.5 million in 2024, then slipped by 24.89% to $22.9 million in 2025, then surged by 45.93% to $33.4 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $33.4 million (Q1 2026), $22.9 million (Q4 2025), and $23.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Lifeward | 11.14 Mn | -263,371.13 | 1.34 Mn | 33.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.42 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 28.81 Mn |
| Dec 31, 2024 | 30.49 Mn |
| Sep 30, 2024 | 45.77 Mn |
| Jun 30, 2024 | 50.98 Mn |
| Mar 31, 2024 | 55.22 Mn |
| Dec 31, 2023 | 63.19 Mn |
| Sep 30, 2023 | 69.22 Mn |
| Jun 30, 2023 | 65.81 Mn |
| Mar 31, 2023 | 68.98 Mn |
| Dec 31, 2022 | 74.24 Mn |
| Sep 30, 2022 | 80.77 Mn |
| Jun 30, 2022 | 85.80 Mn |
| Mar 31, 2022 | 90.00 Mn |
| Dec 31, 2021 | 94.75 Mn |
| Sep 30, 2021 | 98.72 Mn |
| Jun 30, 2021 | 71.71 Mn |